0XOD.L - UroGen Pharma Ltd.

LSE - LSE Delayed Price. Currency in USD

Insider roster

Individual or entity	Most-recent transaction	Date	Shares owned as of transaction date
BARRETT ELIZABETH A Chief Executive Officer	Conversion of Exercise of derivative security	31 Jan 2023	326,691
BELLDEGRUN ARIE S Director	Conversion of Exercise of derivative security	14 Sept 2022	408,693
COHEN FREDERICK E. M.D. PH.D. Director	Conversion of Exercise of derivative security	06 Feb 2019	15,000
HENDERSON MOLLY Chief Financial Officer	Sale	31 Jan 2022	5,248
MULLENNIX STEPHEN L Chief Operating Officer	Sale	27 Apr 2020	10,084
PFREUNDSCHUH PETER P Chief Financial Officer	Sale	15 Oct 2020	10,405
SCHOENBERG MARK Officer	Sale	31 Jan 2023	148,560
SMITH JASON DREW General Counsel	Sale	31 Jan 2023	13,873
*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.